Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Nov;52(11):2822–2835. doi: 10.1172/JCI107478

The Metabolism of Cholestanol, Cholesterol, and Bile Acids in Cerebrotendinous Xanthomatosis

Gerald Salen 1,2, Scott M Grundy 1,2
PMCID: PMC302550  PMID: 4355999

Abstract

The metabolism of cholesterol and its 5-dihydro derivative, cholestanol, was investigated by means of sterol balance and isotope kinetic techniques in 3 subjects with cerebrotendinous xanthomatosis (CTX) and 11 other individuals. All subjects were hospitalized on a metabolic ward and were fed diets practically free of cholesterol and cholestanol. After the intravenous administration of [1,2-3H]cholestanol, the radioactive sterol was transported and esterified in plasma lipoproteins in an identical manner to cholesterol. In these short-term experiments, the specific activity-time curves of plasma cholestanol conformed to two-pool models in both the CTX and control groups. However, cholestanol plasma concentrations, total body miscible pools, and daily synthesis rates were two to five times greater in the CTX than control individuals. The short-term specific activity decay curves of plasma [4-14C]cholesterol also conformed to two-pool models in both groups. However, in the CTX subjects the decay was more rapid, and daily cholesterol synthesis was nearly double that of the control subjects. Plasma concentrations and the sizes of the rapidly turning over pool of exchangeable cholesterol were apparently small in the CTX subjects, and these measurements did not correlate with the large cholesterol deposits found in tendon and tuberous xanthomas.

Despite active cholesterol synthesis, bile acid formation was subnormal in the CTX subjects. However, bile acid sequestration was accompanied by a rise in plasma cholestanol levels and greatly augmented fecal cholestanol outputs. In contrast, the administration of clofibrate lowered plasma cholesterol levels 50% and presumably reduced synthesis in the CTX subjects. Plasma cholesterol concentrations and fecal steroid excretion did not change significantly during this therapy.

These findings indicate that the excessive tissue deposits of cholesterol and cholestanol that characterize CTX were associated with hyperactive neutral sterol synthesis. The demonstration of subnormal bile acid formation suggests that defective bile acid synthesis may predispose to the neutral sterol abnormalities.

Full text

PDF
2822

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrens E. H., Jr The use of liquid formula diets in metabolic studies: 15 years' experience. Adv Metab Disord. 1970;4:297–332. doi: 10.1016/b978-0-12-027304-1.50013-2. [DOI] [PubMed] [Google Scholar]
  2. Bhattacharyya A. K., Connor W. E., Spector A. A. Excretion of sterols from the skin of normal and hypercholesterolemic humans. Implications for sterol balance studies. J Clin Invest. 1972 Aug;51(8):2060–2070. doi: 10.1172/JCI107012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davignon J., Simmonds W. J., Ahrens E. H. Usefulness of chromic oxide as an internal standard for balance studies in formula-fed patients and for assessment of colonic function. J Clin Invest. 1968 Jan;47(1):127–138. doi: 10.1172/JCI105703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 19;276(3):148–contd. doi: 10.1056/NEJM196701192760305. [DOI] [PubMed] [Google Scholar]
  5. GRUNDY S. M., AHRENS E. H., Jr, MIETTINEN T. A. QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS. J Lipid Res. 1965 Jul;6:397–410. [PubMed] [Google Scholar]
  6. GURPIDE E., MANN J., SANDBERG E. DETERMINATION OF KINETIC PARAMETERS INA TWO-POOL SYSTEM BY ADMINISTRATION OF ONE OR MORE TRACERS. Biochemistry. 1964 Sep;3:1250–1255. doi: 10.1021/bi00897a012. [DOI] [PubMed] [Google Scholar]
  7. Garbutt J. T., Kenney T. J. Effect of cholestyramine on bile acid metabolism in normal man. J Clin Invest. 1972 Nov;51(11):2781–2789. doi: 10.1172/JCI107100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goodman D. S., Noble R. P., Dell R. B. Three-pool model of the long-term turnover of plasma cholesterol in man. J Lipid Res. 1973 Mar;14(2):178–188. [PubMed] [Google Scholar]
  9. Goodman D. S., Noble R. P. Turnover of plasma cholesterol in man. J Clin Invest. 1968 Feb;47(2):231–241. doi: 10.1172/JCI105719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grundy S. M., Ahrens E. H., Jr Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods. J Lipid Res. 1969 Jan;10(1):91–107. [PubMed] [Google Scholar]
  11. Grundy S. M., Ahrens E. H., Jr, Salen G. Dietary beta-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies. J Lipid Res. 1968 May;9(3):374–387. [PubMed] [Google Scholar]
  12. Grundy S. M., Ahrens E. H., Jr, Salen G., Schreibman P. H., Nestel P. J. Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lipid Res. 1972 Jul;13(4):531–551. [PubMed] [Google Scholar]
  13. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harlan W. R., Jr, Still W. J. Hereditary tendinous and tuberous xanthomatosis without hyperlipidemia. A new lipid-storage disorder. N Engl J Med. 1968 Feb 22;278(8):416–422. doi: 10.1056/NEJM196802222780803. [DOI] [PubMed] [Google Scholar]
  15. Hughes J. D., Meriwether T. W., 3rd Familial pseudohypertrophy of tendo-achillis with multisystem disease. South Med J. 1971 Mar;64(3):311–316. doi: 10.1097/00007611-197103000-00014. [DOI] [PubMed] [Google Scholar]
  16. MIETTINEN T. A., AHRENS E. H., Jr, GRUNDY S. M. QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL DIETARY AND FECAL NEUTRAL STEROIDS. J Lipid Res. 1965 Jul;6:411–424. [PubMed] [Google Scholar]
  17. MOSBACH E. H., BLUM J., ARROYO E., MILCHS A new method for the determination of dihydrocholesterol in tissues. Anal Biochem. 1963 Feb;5:158–169. doi: 10.1016/0003-2697(63)90022-8. [DOI] [PubMed] [Google Scholar]
  18. Menkes J. H., Schimschock J. R., Swanson P. D. Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system. Arch Neurol. 1968 Jul;19(1):47–53. doi: 10.1001/archneur.1968.00480010065004. [DOI] [PubMed] [Google Scholar]
  19. Nestel P. J., Whyte H. M., Goodman D. S. Distribution and turnover of cholesterol in humans. J Clin Invest. 1969 Jun;48(6):982–991. doi: 10.1172/JCI106079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PIPER J., ORRILD L. Essential familial hypercholesterolemia and xanthomatosis; follow-up study of twelve Danish families. Am J Med. 1956 Jul;21(1):34–46. doi: 10.1016/0002-9343(56)90006-7. [DOI] [PubMed] [Google Scholar]
  21. Rosenfeld R. S., Zumoff B., Hellman L. Conversion of cholesterol injected into man to cholestanol via a 3-ketonic intermediate. J Lipid Res. 1967 Jan;8(1):16–23. [PubMed] [Google Scholar]
  22. Salen G., Ahrens E. H., Jr, Grundy S. M. Metabolism of beta-sitosterol in man. J Clin Invest. 1970 May;49(5):952–967. doi: 10.1172/JCI106315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Salen G. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. Ann Intern Med. 1971 Dec;75(6):843–851. doi: 10.7326/0003-4819-75-6-843. [DOI] [PubMed] [Google Scholar]
  24. Salen G., Polito A. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis. J Clin Invest. 1972 Jan;51(1):134–140. doi: 10.1172/JCI106783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Samuel P., Lieberman S. Improved estimation of body masses and turnover of cholesterol by computerized input--output analysis. J Lipid Res. 1973 Mar;14(2):189–196. [PubMed] [Google Scholar]
  26. Samuel P., Perl W., Holtzman C. M., Rochman N. D., Lieberman S. Long-term kinetics of serum and xanthoma cholesterol radioactivity in patients with hypercholesterolemia. J Clin Invest. 1972 Feb;51(2):266–278. doi: 10.1172/JCI106811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schimschock J. R., Alvord E. C., Jr, Swanson P. D. Cerebrotendinous xanthomatosis. Clinical and pathological studies. Arch Neurol. 1968 Jun;18(6):688–698. doi: 10.1001/archneur.1968.00470360110011. [DOI] [PubMed] [Google Scholar]
  28. Shefer S., Hauser S., Mosbach E. H. Biosynthesis of cholestanol: 5-alpha-cholestan-3-one reductase of rat liver. J Lipid Res. 1966 Nov;7(6):763–771. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES